Skip to content

The Effectiveness of Mindfulness Based Cognitive Therapy on the quality of life, depression and plasma level of cortisol in patients with breast cancer and depressed people

The Effectiveness of Mindfulness Based Cognitive Therapy (MBCT) on the quality of life, depression and plasma level of cortisol in patients with breast cancer and depressed people

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211031052929N1
Enrollment
60
Registered
2022-01-10
Start date
2021-01-11
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Breast Cancer. Condition 2: Depressed People. Malignant neoplasm of breast Major depressive disorder, single episode, moderate

Interventions

Intervention 1: intervention group: mindfulness-based cognitive therapy : 1- Introduction of the program, structure an

Sponsors

Islamic Azad University of Shiraz Branch
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Satisfaction to participate in research the age range between 18 to 75 Major depressive disorder based on DSM - V Score between 20 to 28 in the second edition of the Beck Depression Scale At least fifth elementary degree Clinical diagnosis of stage 0 to 3 breast cancer based on clinical findings of cytology and physician diagnosis (in the group of people with cancer)

Exclusion criteria

Exclusion criteria: Men with breast cancer(in the group of people with cancer) Metastasis to other organs of the body including liver, kidney and brain (in the group of people with cancer) Spectrum of schizophrenia and other psychotic disorders, bipolar and related disorders Substance Abuse Disorders Taking drugs that affect the psyche and antidepressants Common meditation or yoga exercises during the last three months before entering the study History of participating in a mindfulness program at the time of project implementation

Design outcomes

Primary

MeasureTime frame
Depression score in Beck questionnaire (BDI-II). Timepoint: Before and after intervention. Method of measurement: Beck depression questionnaire (BDI-II).;Quality of life score in the questionnaire SF36. Timepoint: Before and after intervention. Method of measurement: SF36 quality of life questionnaire.;Serum cortisol levels. Timepoint: Before and after intervention. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Olyaee

Islamic Azad University of Shiraz

olyaiez@yahoo.com07136410041-44

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026